Literature DB >> 20878717

A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome.

Philip S Boonstra1, Stephen B Gruber, Victoria M Raymond, Shu-Chen Huang, Susanne Timshel, Mef Nilbert, Bhramar Mukherjee.   

Abstract

Anticipation, manifested through decreasing age of onset or increased severity in successive generations, has been noted in several genetic diseases. Statistical methods for genetic anticipation range from a simple use of the paired t-test for age of onset restricted to affected parent-child pairs to a recently proposed random effects model which includes extended pedigree data and unaffected family members [Larsen et al., 2009]. A naive use of the paired t-test is biased for the simple reason that age of onset has to be less than the age at ascertainment (interview) for both affected parent and child, and this right truncation effect is more pronounced in children than in parents. In this study, we first review different statistical methods for testing genetic anticipation in affected parent-child pairs that address the issue of bias due to right truncation. Using affected parent-child pair data, we compare the paired t-test with the parametric conditional maximum likelihood approach of Huang and Vieland [1997] and the nonparametric approach of Rabinowitz and Yang [1999] in terms of Type I error and power under various simulation settings and departures from the modeling assumptions. We especially investigate the issue of multiplex ascertainment and its effect on the different methods. We then focus on exploring genetic anticipation in Lynch syndrome and analyze new data on the age of onset in affected parent-child pairs from families seen at the University of Michigan Cancer Genetics clinic with a mutation in one of the three main mismatch repair (MMR) genes. In contrast to the clinic-based population, we re-analyze data on a population-based Lynch syndrome cohort, derived from the Danish HNPCC-register. Both datasets indicate evidence of genetic anticipation in Lynch syndrome. We then expand our review to incorporate recently proposed statistical methods that consider family instead of affected pairs as the sampling unit. These prospective censored regression models offer additional flexibility to incorporate unaffected family members, familial correlation and other covariates into the analysis. An expanded dataset from the Danish HNPCC-register is analyzed by this alternative set of methods.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20878717      PMCID: PMC3894615          DOI: 10.1002/gepi.20534

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  25 in total

1.  Assessing changes in ages at onset over successive generation: an application to breast cancer.

Authors:  L Hsu; L P Zhao; K E Malone; J R Daling
Journal:  Genet Epidemiol       Date:  2000-01       Impact factor: 2.135

2.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

3.  Using evidence for population stratification bias in combined individual- and family-level genetic association analyses of quantitative traits.

Authors:  Lucia Mirea; Lei Sun; James E Stafford; Shelley B Bull
Journal:  Genet Epidemiol       Date:  2010-07       Impact factor: 2.135

4.  Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease.

Authors:  M F Picco; S Goodman; J Reed; T M Bayless
Journal:  Ann Intern Med       Date:  2001-06-19       Impact factor: 25.391

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Classics in oncology. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913. By Aldred Scott Warthin. 1913.

Authors: 
Journal:  CA Cancer J Clin       Date:  1985 Nov-Dec       Impact factor: 508.702

7.  Variable age of onset in hereditary nonpolyposis colorectal cancer: clinical implications.

Authors:  F H Menko; G J te Meerman; J R Sampson
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

8.  Establishment of a hereditary nonpolyposis colorectal cancer registry.

Authors:  M A Rodríguez-Bigas; P H Lee; L O'Malley; T K Weber; O Suh; G R Anderson; N J Petrelli
Journal:  Dis Colon Rectum       Date:  1996-06       Impact factor: 4.585

9.  Age-at-interview bias in anticipation studies: computer simulations and an example with panic disorder.

Authors:  G A Heiman; S E Hodge; P Wickramaratne; H Hsu
Journal:  Psychiatr Genet       Date:  1996       Impact factor: 2.458

10.  Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.

Authors:  H F Vasen; B G Taal; G Griffioen; F M Nagengast; A Cats; F H Menko; W Oskam; J H Kleibeuker; G J Offerhaus; P M Khan
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

View more
  17 in total

1.  Fertility and apparent genetic anticipation in Lynch syndrome.

Authors:  Douglas Stupart; Aung Ko Win; Mark Jenkins; Ingrid M Winship; Paul Goldberg; Rajkumar Ramesar
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

Review 2.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Bayesian modeling for genetic anticipation in presence of mutational heterogeneity: a case study in Lynch syndrome.

Authors:  Philip S Boonstra; Bhramar Mukherjee; Jeremy M G Taylor; Mef Nilbert; Victor Moreno; Stephen B Gruber
Journal:  Biometrics       Date:  2011-05-31       Impact factor: 2.571

4.  Epilepsy in families: Age at onset is a familial trait, independent of syndrome.

Authors:  Colin A Ellis; Leonid Churilov; Michael P Epstein; Sharon X Xie; Susannah T Bellows; Ruth Ottman; Samuel F Berkovic
Journal:  Ann Neurol       Date:  2019-05-20       Impact factor: 10.422

Review 5.  Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC).

Authors:  Mei Hua Wong; Chuen Seng Tan; Soo Chin Lee; Yvonne Yong; Aik Seng Ooi; Joanne Ngeow; Min Han Tan
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

6.  No evidence of genetic anticipation in a large family with Lynch syndrome.

Authors:  D Stupart; P Goldberg; U Algar; A Vorster; R Ramesar
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

7.  Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension.

Authors:  Emma K Larkin; John H Newman; Eric D Austin; Anna R Hemnes; Lisa Wheeler; Ivan M Robbins; James D West; John A Phillips; Rizwan Hamid; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2012-08-23       Impact factor: 21.405

8.  Ascertainment bias causes false signal of anticipation in genetic prion disease.

Authors:  Eric Vallabh Minikel; Inga Zerr; Steven J Collins; Claudia Ponto; Alison Boyd; Genevieve Klug; André Karch; Joanna Kenny; John Collinge; Leonel T Takada; Sven Forner; Jamie C Fong; Simon Mead; Michael D Geschwind
Journal:  Am J Hum Genet       Date:  2014-10-02       Impact factor: 11.025

9.  Age at Death of Creutzfeldt-Jakob disease in subsequent family generation carrying the E200K mutation of the prion protein gene.

Authors:  Maurizio Pocchiari; Anna Poleggi; Maria Puopolo; Marco D'Alessandro; Dorina Tiple; Anna Ladogana
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Telomere length and genetic anticipation in Lynch syndrome.

Authors:  Nuria Seguí; Marta Pineda; Elisabet Guinó; Ester Borràs; Matilde Navarro; Fernando Bellido; Victor Moreno; Conxi Lázaro; Ignacio Blanco; Gabriel Capellá; Laura Valle
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.